정맥천자 시술 시장 : 제품 유형, 정맥 유형, 기술, 용도, 최종 사용자, 지역별 세계 분석, 예측(-2032년)

According to Stratistics MRC, the Global Venipuncture Procedure Market is accounted for $1.42 billion in 2025 and is expected to reach $2.43 billion by 2032 growing at a CAGR of 8.0% during the forecast period. Venipuncture is a medical procedure that involves puncturing a vein with a needle to withdraw blood or administer medications and fluids. Commonly performed on the arm, it is essential for diagnostic testing, transfusions, and intravenous therapy. The procedure requires skill to ensure minimal discomfort and reduce complications. It is routinely conducted in hospitals, clinics, and laboratories by trained healthcare professionals such as phlebotomists, nurses, or medical technicians.

According to the Centers for Disease Control and Prevention data published in 2021. Every year, about 805,000 people in the U.S. suffered with heart attack and about 1 in 20 adults aged 20 and older have coronary artery disease (CAD).

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The increasing prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular conditions, is driving the demand for venipuncture procedures. Chronic diseases often require routine blood tests for diagnosis, treatment monitoring, and management, thus boosting the market. With advancements in healthcare infrastructure and diagnostic tools, access to venipuncture services has improved significantly. This growing demand is further supported by government initiatives promoting early diagnosis and preventive healthcare. Additionally, an aging population prone to chronic conditions adds to the necessity of venipuncture services.

Restraint:

Shortage of trained phlebotomists

The venipuncture procedure market is restrained by a notable shortage of skilled phlebotomists. Properly trained personnel are crucial to ensure safe and effective blood collection, minimizing the risk of errors and patient discomfort. The lack of adequate training programs and certifications in many regions exacerbates this issue. Moreover, high staff turnover in the healthcare sector contributes to the scarcity of experienced professionals. This challenge is particularly pronounced in rural and underdeveloped areas, where healthcare resources are limited.

Opportunity:

Growth in outpatient and home care services

The increasing preference for outpatient care and home healthcare services presents a significant opportunity for the venipuncture procedure market. These settings offer convenience, reduced costs, and enhanced patient comfort, driving their adoption. The expansion of point-of-care testing and portable diagnostic devices further supports this trend. Advances in technology enable precise venipuncture procedures outside traditional clinical environments. Moreover, the rising demand for personalized healthcare solutions aligns with the growth of these services.

Threat:

Rising preference for non-invasive diagnostic alternatives

The growing popularity of non-invasive diagnostic techniques poses a threat to the venipuncture procedure market. Methods such as saliva, urine, and breath tests offer a less invasive and more patient-friendly alternative to blood collection. These technologies are particularly appealing to patients who experience anxiety or discomfort during venipuncture. Additionally, advancements in wearable health monitoring devices are reducing the need for frequent blood draws. As these alternatives become more accessible and reliable, they may displace traditional venipuncture procedures.

Covid-19 Impact

The COVID-19 pandemic significantly impacted the venipuncture procedure market. During the initial phases, lockdowns and healthcare system disruptions led to a decline in non-urgent blood tests and diagnostics. However, the pandemic also highlighted the importance of timely diagnostic services, leading to an eventual recovery. Post-pandemic, heightened awareness about regular health check-ups and diagnostics is expected to drive growth. The pandemic underscored the critical role of venipuncture in healthcare, reinforcing its importance in the long term.

The cephalic vein segment is expected to be the largest during the forecast period

The cephalic vein segment is expected to account for the largest market share during the forecast period, due to its accessibility and ease of use for blood collection. This vein is commonly chosen for venipuncture procedures, especially in outpatient and emergency settings. Its prominent location minimizes complications and enhances patient comfort, increasing its preference among healthcare professionals. Additionally, the growing demand for routine diagnostics and chronic disease monitoring further drives the utilization of cephalic vein.

The hospitals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals segment is predicted to witness the highest growth rate, due to their role as primary providers of venipuncture services. Hospitals handle a high volume of diagnostic and therapeutic procedures requiring blood collection, driving their market share. The integration of advanced technologies and automation in hospital labs enhances the accuracy and efficiency of venipuncture processes. Additionally, hospitals' ability to cater to complex cases and emergency situations positions them as key players in the market.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to its rapidly expanding healthcare infrastructure. The region's large population and increasing prevalence of chronic diseases drive the demand for venipuncture procedures. Government initiatives promoting early disease detection and preventive care further enhance market growth. Additionally, rising disposable incomes and improved access to healthcare services contribute to increased diagnostic activities.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to its advanced healthcare systems and high diagnostic test volumes. The region benefits from extensive healthcare investments and a strong focus on research and development. Innovations in diagnostic technologies and automation support the efficient conduct of venipuncture procedures. Moreover, increasing awareness about preventive healthcare and routine check-ups drives the market.

Key players in the market

Some of the key players profiled in the Venipuncture Procedure Market include Becton, Dickinson and Company (BD), Terumo Corporation, Quest Diagnostics, Greiner Bio-One International, Fresenius Kabi AG, AccuVein Inc., Smiths Medical, B. Braun Medical, Christie Medical Holdings, Inc., TransLite, LLC, Sharn Anesthesia, Laboratory Corporation of America Holdings (LabCorp), Eurofins Scientific, BioReference Health, LLC, and UNILABS.

Key Developments:

In April 2025, BD announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) and the commercial launch of Phasix(TM) ST Umbilical Hernia Patch, the first and only fully absorbable hernia patch on the market designed specifically for umbilical hernias.

In March 2025, Terumo Vietnam Medical Equipment and Daiichi Sankyo Vietnam have signed a Memorandum of Understanding (MoU) to collaborate on advancing cardiovascular expertise in Vietnam. The initiative aims to support healthcare professionals in updating their knowledge and skills in interventional cardiology.

Product Types Covered:

• Needles
• Syringes
• Blood Collection Tubes
• Other Product Types

Vein Types Covered:

• Median Cubital Vein
• Cephalic Vein
• Basilic Vein
• Other Veins

Techniques Covered:

• Straight Needle Technique
• Butterfly Needle Technique
• Vacutainer Method
• Other Techniques

Applications Covered:

• Diagnostic Testing
• Blood Donation
• Therapeutic Phlebotomy
• Intravenous Therapy
• Other Applications

End Users Covered:

• Hospitals
• Diagnostic Laboratories
• Physician Offices/Clinics
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Technology Analysis
• 3.8 Application Analysis
• 3.9 End User Analysis
• 3.10 Emerging Markets
• 3.11 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Venipuncture Procedure Market, By Product Type

• 5.1 Introduction
• 5.2 Needles
• 5.3 Syringes
• 5.4 Blood Collection Tubes
• 5.5 Other Product Types

6 Global Venipuncture Procedure Market, By Vein Type

• 6.1 Introduction
• 6.2 Median Cubital Vein
• 6.3 Cephalic Vein
• 6.4 Basilic Vein
• 6.5 Other Veins

7 Global Venipuncture Procedure Market, By Technique

• 7.1 Introduction
• 7.2 Straight Needle Technique
• 7.3 Butterfly Needle Technique
• 7.4 Vacutainer Method
• 7.5 Other Techniques

8 Global Venipuncture Procedure Market, By Application

• 8.1 Introduction
• 8.2 Diagnostic Testing
• 8.3 Blood Donation
• 8.4 Therapeutic Phlebotomy
• 8.5 Intravenous Therapy
• 8.6 Other Applications

9 Global Venipuncture Procedure Market, By End User

• 9.1 Introduction
• 9.2 Hospitals
• 9.3 Diagnostic Laboratories
• 9.4 Physician Offices/Clinics
• 9.5 Other End Users

10 Global Venipuncture Procedure Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Becton, Dickinson and Company (BD)
• 12.2 Terumo Corporation
• 12.3 Quest Diagnostics
• 12.4 Greiner Bio-One International
• 12.5 Fresenius Kabi AG
• 12.6 AccuVein Inc.
• 12.7 Smiths Medical
• 12.8 B. Braun Medical
• 12.9 Christie Medical Holdings, Inc.
• 12.10 TransLite, LLC
• 12.11 Sharn Anesthesia
• 12.12 Laboratory Corporation of America Holdings (LabCorp)
• 12.13 Eurofins Scientific
• 12.14 BioReference Health, LLC
• 12.15 UNILABS